Résultats de la recherche

Search Pages webPDF

Les résultats s’affichent automatiquement selon le filtre sélectionné.

Filtres
Communiqué de presse
Forms
Manuel des politiques opérationnelles
Page
Mots-clés
FAQ
Formulaires
Profil du fournisseur
991 résultat(s) trouvé(s)
Drug formulary listing decision – Buprenorphine for opioid use disorder
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection Indication(s) Buprenorphine/naloxone sublingual (SL) tablet (…
Drug formulary listing decision – Buprenorphine in treatment of chronic pain
Burpenorphine transdermal patch - butrans® and burprenorphine buccal soluble film belbuca®Indication(s)The management of pain severe enough to require daily, continuous, long…
Drug formulary listing decision – Calcitonin Gene-Related Peptide Monoclonal Antibodies in prevention of migraine
Indication Prevention of migraine in adults who have at least four migraine days per month. Formulary Status The WSIB Drug Advisory Committee (DAC) recommended that…
Drug formulary listing decision – Compounded topical analgesics
Indication(s)Compounded topical analgesics have not been approved by Health Canada and thus have no official indication for the topical treatment of pain.Formulary statusThe…
Drug formulary listing decision – Corticosteroid injections in musculoskeletal conditions
Corticosteroid injections in musculoskeletal conditions Indications/Clinical uses Treatment of acute and chronic musculoskeletal conditions including neck and upper…